SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000912057-02-038596
Filing Date
2002-10-15
Accepted
2002-10-15 11:48:28
Documents
5
Period of Report
2002-11-13
Effectiveness Date
2002-10-15

Document Format Files

Seq Description Document Type Size
1 DEF 14A a2090830zdef14a.htm DEF 14A 139271
4 G508740.JPG g508740.jpg GRAPHIC 6391
5 G41827.JPG g41827.jpg GRAPHIC 5820
6 G679160.JPG g679160.jpg GRAPHIC 4679
7 G904200.JPG g904200.jpg GRAPHIC 33481
  Complete submission text file 0000912057-02-038596.txt   191569
Mailing Address 390 WAKARA WAY SALT LAKE CITY UT 84108
Business Address 320 WAKARA WAY SALT LAKE CITY UT 84108
MYRIAD GENETICS INC (Filer) CIK: 0000899923 (see all company filings)

IRS No.: 870494517 | State of Incorp.: DE | Fiscal Year End: 0630
Type: DEF 14A | Act: 34 | File No.: 000-26642 | Film No.: 02788630
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
Office of Life Sciences